Sora Ely, MD, Joins the George Washington University Cancer Center’s Thoracic Oncology Program

Sora Ely, MD

Sora Ely, MD, has joined the George Washington (GW) University Cancer Center and the GW Medical Faculty Associates as a Thoracic Surgeon. She treats benign and malignant pathologies of the chest and foregut. Her clinical interests include lung cancer screening, treatment of lung and esophageal cancer, treatment of mediastinal masses, including thymoma, and benign foregut surgery. Ely offers both laparoscopic/thoracoscopic and robotic-assisted minimally invasive surgical techniques for her patients.

“I am thrilled to join such an excellent multidisciplinary thoracic oncology team at GW that shares my commitment to providing the best possible patient care through a team-based, patient-centered approach,” said Ely. “I am dedicated to individualized care for my patients and to treating every patient like I would a family member.”

Ely comes to GW after completing her Thoracic Surgery fellowship at the Yale School of Medicine, during which she completed advanced robotic training as a recipient of the American Association of Thoracic Surgeons (AATS) Thoracic Surgical Robotics Fellowship. She completed her General Surgery residency at UCSF East Bay and earned her medical degree from the Tulane University School of Medicine. She is board-certified in General Surgery and board-eligible in Thoracic Surgery.

“I am passionate about improving participation in lung cancer screening and am excited to be a part of the development of a sister program to follow up incidentally-discovered (as opposed to screening-detected) lung nodules, which will aim to prevent these patients from ‘falling through the cracks’ and will be the first program of its kind in the DC area,” said Ely.

Latest News

What do you get when you combine a love of psychology with a keen interest in medicine? Clinical social worker Jessica Gelfarb knows that answer well. With one foot in both worlds, she helps GW Cancer Center patients navigate their most challenging life journeys. While she guides them through the…
Robert H. Miller’s appointment as interim vice provost for research will further build on progress led by Pamela M. Norris
Vishal Patel, MD, FAAD, FACMS, highlights the evolving role of PD-1 inhibitors in the management of nonmelanoma skin cancers.